Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia
低强度化疗联合inotuzumab ozogamicin、blinatumomab和rituximab治疗复发/难治性B细胞急性淋巴细胞白血病患儿
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2023.284950
Gibson, Amber; Nunez, Cesar; Robusto, Lindsay; Kammerer, Brianna; Garcia, Miriam; Roth, Michael; Sheth, Rachna; Tewari, Priti; Hittle, Aline; Toepfer, Laurie; Torres, Romeo; Short, Nicholas J; Jabbour, Elias; Jain, Nitin; Cuglievan, Branko; McCall, David